Takeda expands into Brazil
Japan\'s largest drugmaker, Takeda Pharmaceutical Company, is to set up a subsidiary in Brazil.
Japan's largest drugmaker, Takeda Pharmaceutical Company, is to set up a subsidiary in Brazil.
The new subsidiary, to be based in Sao Paulo, will import and distribute Takeda products for the Brazilian market. It will begin operations from February 2010.
"Combined with Takeda's additional recent expansions, this opportunity will drive Takeda's ability to maximise the potential of our pipeline in Brazil," said Alan MacKenzie, executive vice president of international operations at Takeda Pharmaceuticals International. "Brazil is an important country in the Latin American region for Takeda to ensure we are providing our products where patients need them."
The Brazilian pharmaceutical market accounts for more than 40% of pharmaceutical sales throughout Latin America and is forecasted to grow by 8.5% every year until 2013.
The move represents the 12th new strategic expansion for Takeda this year, following Canada, Spain, Portugal, Ireland, Mexico, Sweden, Norway, Denmark, Belgium, Luxembourg and Turkey.
The company is also said to be studying the possibility of entering India and has appointed Shankar Suryanarayanan, formerly with Roche, to research the Indian market. The company might make an acquisition or form an alliance, but said no final decision had yet been made.
